HealthEquity Statistics
Total Valuation
HealthEquity has a market cap or net worth of $9.65 billion. The enterprise value is $10.47 billion.
Market Cap | 9.65B |
Enterprise Value | 10.47B |
Important Dates
The last earnings date was Tuesday, June 3, 2025, after market close.
Earnings Date | Jun 3, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HealthEquity has 86.48 million shares outstanding. The number of shares has increased by 1.53% in one year.
Current Share Class | 86.48M |
Shares Outstanding | 86.48M |
Shares Change (YoY) | +1.53% |
Shares Change (QoQ) | -0.22% |
Owned by Insiders (%) | 1.91% |
Owned by Institutions (%) | 109.68% |
Float | 84.79M |
Valuation Ratios
The trailing PE ratio is 81.50 and the forward PE ratio is 28.81. HealthEquity's PEG ratio is 1.38.
PE Ratio | 81.50 |
Forward PE | 28.81 |
PS Ratio | 7.80 |
Forward PS | 9.74 |
PB Ratio | 4.55 |
P/TBV Ratio | n/a |
P/FCF Ratio | 28.56 |
P/OCF Ratio | 28.44 |
PEG Ratio | 1.38 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.80, with an EV/FCF ratio of 30.99.
EV / Earnings | 85.92 |
EV / Sales | 8.42 |
EV / EBITDA | 25.80 |
EV / EBIT | 42.99 |
EV / FCF | 30.99 |
Financial Position
The company has a current ratio of 4.06, with a Debt / Equity ratio of 0.52.
Current Ratio | 4.06 |
Quick Ratio | 3.47 |
Debt / Equity | 0.52 |
Debt / EBITDA | 2.70 |
Debt / FCF | 3.28 |
Interest Coverage | 3.82 |
Financial Efficiency
Return on equity (ROE) is 5.77% and return on invested capital (ROIC) is 4.82%.
Return on Equity (ROE) | 5.77% |
Return on Assets (ROA) | 4.57% |
Return on Invested Capital (ROIC) | 4.82% |
Return on Capital Employed (ROCE) | 7.38% |
Revenue Per Employee | $398,404 |
Profits Per Employee | $39,040 |
Employee Count | 3,120 |
Asset Turnover | 0.37 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, HealthEquity has paid $31.94 million in taxes.
Income Tax | 31.94M |
Effective Tax Rate | 20.78% |
Stock Price Statistics
The stock price has increased by +31.48% in the last 52 weeks. The beta is 0.49, so HealthEquity's price volatility has been lower than the market average.
Beta (5Y) | 0.49 |
52-Week Price Change | +31.48% |
50-Day Moving Average | 91.63 |
200-Day Moving Average | 93.43 |
Relative Strength Index (RSI) | 74.26 |
Average Volume (20 Days) | 1,201,966 |
Short Selling Information
The latest short interest is 5.82 million, so 6.73% of the outstanding shares have been sold short.
Short Interest | 5.82M |
Short Previous Month | 6.17M |
Short % of Shares Out | 6.73% |
Short % of Float | 6.86% |
Short Ratio (days to cover) | 6.43 |
Income Statement
In the last 12 months, HealthEquity had revenue of $1.24 billion and earned $121.81 million in profits. Earnings per share was $1.37.
Revenue | 1.24B |
Gross Profit | 814.43M |
Operating Income | 243.45M |
Pretax Income | 98.27M |
Net Income | 121.81M |
EBITDA | 405.70M |
EBIT | 243.45M |
Earnings Per Share (EPS) | $1.37 |
Balance Sheet
The company has $287.89 million in cash and $1.11 billion in debt, giving a net cash position of -$818.86 million or -$9.47 per share.
Cash & Cash Equivalents | 287.89M |
Total Debt | 1.11B |
Net Cash | -818.86M |
Net Cash Per Share | -$9.47 |
Equity (Book Value) | 2.12B |
Book Value Per Share | 24.49 |
Working Capital | 356.45M |
Cash Flow
In the last 12 months, operating cash flow was $339.17 million and capital expenditures -$1.45 million, giving a free cash flow of $337.72 million.
Operating Cash Flow | 339.17M |
Capital Expenditures | -1.45M |
Free Cash Flow | 337.72M |
FCF Per Share | $3.91 |
Margins
Gross margin is 65.52%, with operating and profit margins of 19.59% and 9.80%.
Gross Margin | 65.52% |
Operating Margin | 19.59% |
Pretax Margin | 12.37% |
Profit Margin | 9.80% |
EBITDA Margin | 32.64% |
EBIT Margin | 19.59% |
FCF Margin | 27.17% |
Dividends & Yields
HealthEquity does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.53% |
Shareholder Yield | -1.53% |
Earnings Yield | 1.26% |
FCF Yield | 3.50% |
Analyst Forecast
The average price target for HealthEquity is $117.00, which is 4.89% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $117.00 |
Price Target Difference | 4.89% |
Analyst Consensus | Strong Buy |
Analyst Count | 12 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HealthEquity has an Altman Z-Score of 4.39 and a Piotroski F-Score of 6.
Altman Z-Score | 4.39 |
Piotroski F-Score | 6 |